ACE Inhibitors News and Research

RSS
ACE inhibitors act to reduce hypertension by interfering with the conversion of angiotensin I to artery-constricting angiotensin II. Blocking the production of angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. ACE inhibitors currently are recommended as first-line therapy for hypertension in certain patient populations, because of their safety and efficacy.
Amgen announces phase 3 ivabradine data for treatment of chronic HF

Amgen announces phase 3 ivabradine data for treatment of chronic HF

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Investigational LCZ696 drug: A real breakthrough for patients with heart failure

Investigational LCZ696 drug: A real breakthrough for patients with heart failure

FDA accepts Symplmed's Prestalia NDA for hypertension treatment

FDA accepts Symplmed's Prestalia NDA for hypertension treatment

New path may lead to powerful adjunctive novel therapy for PTSD treatment

New path may lead to powerful adjunctive novel therapy for PTSD treatment

Researchers emphasize critical need to utilize multi-pronged approach to treat diabetes mellitus

Researchers emphasize critical need to utilize multi-pronged approach to treat diabetes mellitus

PARADIGM-HF trial of LCZ696 for chronic heart failure stopped early for benefit

PARADIGM-HF trial of LCZ696 for chronic heart failure stopped early for benefit

Investigators find effective treatment for life-threatening angioedema attacks in ED

Investigators find effective treatment for life-threatening angioedema attacks in ED

Boston Heart Diagnostics announces commercial launch of FDA-cleared MPO test

Boston Heart Diagnostics announces commercial launch of FDA-cleared MPO test

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

ACE protein overexpression elevates immune responses and prevents Alzheimer's-like cognitive decline

ACE protein overexpression elevates immune responses and prevents Alzheimer's-like cognitive decline

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

New guideline to help doctors treat patients with hypertension

New guideline to help doctors treat patients with hypertension

Oral allergy syndrome sufferers with hypertension may be at increased risk for severe reaction

Oral allergy syndrome sufferers with hypertension may be at increased risk for severe reaction

Simple urine test can help identify disease risks in young type 1 diabetes patients

Simple urine test can help identify disease risks in young type 1 diabetes patients

Heart failure patients may benefit from advanced treatment by heart specialists

Heart failure patients may benefit from advanced treatment by heart specialists

Certain blood pressure medications may reduce risk of dementia due to Alzheimer's disease

Certain blood pressure medications may reduce risk of dementia due to Alzheimer's disease

Personalised therapy can reduce risk of cardiac disease among diabetes patients

Personalised therapy can reduce risk of cardiac disease among diabetes patients